Kathleen M Whalen Hca Healthcare, Inc. (HCA) insider trading activity

Kathleen M Whalen is SVP & Chief Ethics Officer of HCA Healthcare, Inc.. Currently has a direct ownership of 9,454 shares of HCA, which is worth approximately $3.81 Million. The most recent transaction as insider was on Jul 31, 2024, when has been sold 2,987 shares (Common Stock) at a price of $363.51 per share, resulting in proceeds of $1,085,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.45K

16.47% 3M change

7.77% 12M change

Total Value Held $3.81 Million

Kathleen M Whalen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 31 2024	SELL Open market or private sale	$1,085,804 $363.51 p/Share	2,987 Reduced 24.01%	9,454 Common Stock
Jul 29 2024	SELL Payment of exercise price or tax liability	$1,898,757 $358.73 p/Share	5,293 Reduced 27.01%	14,305 Common Stock
Jul 29 2024	SELL Open market or private sale	$670,890 $359.92 p/Share	1,864 Reduced 13.03%	12,441 Common Stock
Jul 29 2024	BUY Exercise of conversion of derivative security	$1,202,587 $145.24 p/Share	8,280 Added 29.7%	19,598 Common Stock
May 17 2024	SELL Payment of exercise price or tax liability	$923,702 $322.86 p/Share	2,861 Reduced 20.18%	11,318 Common Stock
May 17 2024	BUY Exercise of conversion of derivative security	$554,478 $117.35 p/Share	4,725 Added 24.99%	14,179 Common Stock
May 16 2024	SELL Open market or private sale	$1,045,465 $326.3 p/Share	3,204 Reduced 25.31%	9,454 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$315,646 $308.55 p/Share	1,023 Reduced 7.48%	12,658 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	3,780 Added 21.65%	13,681 Common Stock
Feb 14 2024	SELL Bona fide gift	-	349 Reduced 3.4%	9,901 Common Stock
Feb 09 2024	SELL Open market or private sale	$1,305,067 $306.21 p/Share	4,262 Reduced 29.37%	10,250 Common Stock
Feb 05 2024	SELL Payment of exercise price or tax liability	$1,331,938 $310.62 p/Share	4,288 Reduced 22.81%	14,512 Common Stock
Feb 05 2024	BUY Exercise of conversion of derivative security	$720,166 $84.23 p/Share	8,550 Added 31.26%	18,800 Common Stock
Aug 03 2023	SELL Open market or private sale	$787,320 $270.0 p/Share	2,916 Reduced 22.15%	10,250 Common Stock
Feb 17 2023	SELL Open market or private sale	$457,099 $263.61 p/Share	1,734 Reduced 14.83%	9,962 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$356,411 $262.84 p/Share	1,356 Reduced 9.34%	13,166 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	4,560 Added 23.9%	14,522 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$149,471 $255.07 p/Share	586 Reduced 4.77%	11,696 Common Stock
Jan 31 2023	SELL Bona fide gift	-	341 Reduced 3.0%	11,032 Common Stock
Jan 31 2023	BUY Exercise of conversion of derivative security	$86,975 $69.58 p/Share	1,250 Added 9.24%	12,282 Common Stock
May 03 2022	SELL Open market or private sale	$107,690 $215.38 p/Share	500 Reduced 4.21%	11,373 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$298,778 $244.1 p/Share	1,224 Reduced 9.35%	11,873 Common Stock
Feb 18 2022	BUY Grant, award, or other acquisition	-	4,640 Added 26.16%	13,097 Common Stock
Feb 09 2022	SELL Bona fide gift	-	420 Reduced 4.73%	8,457 Common Stock
Nov 04 2021	SELL Open market or private sale	$955,581 $250.48 p/Share	3,815 Reduced 30.06%	8,877 Common Stock

KMW

Kathleen M Whalen

SVP & Chief Ethics Officer

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCA shares.

Notify only if

Value

Insider Trading

Get notified when an Hca Healthcare, Inc. insider buys or sells HCA shares.

Notify only if

Operation

Value

Type

News

Receive news related to HCA Healthcare, Inc.

Track Activities on HCA

Account